Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Shares Outstanding (Weighted Average) (2016 - 2024)

Aethlon Medical (AEMD) has disclosed Shares Outstanding (Weighted Average) for 14 consecutive years, with $174529.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Shares Outstanding (Weighted Average) fell 92.95% year-over-year to $174529.0, compared with a TTM value of $174529.0 through Dec 2024, down 92.95%, and an annual FY2024 reading of $314097.0, down 84.71% over the prior year.
  • Shares Outstanding (Weighted Average) was $174529.0 for Q4 2024 at Aethlon Medical, roughly flat from $174220.0 in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $15.5 million in Q2 2022 and bottomed at $174220.0 in Q3 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $6.8 million, with a median of $2.9 million recorded in 2020.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 816.23% in 2020, then tumbled 92.99% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $12.1 million in 2020, then increased by 20.26% to $14.5 million in 2021, then crashed by 84.22% to $2.3 million in 2022, then grew by 7.96% to $2.5 million in 2023, then tumbled by 92.95% to $174529.0 in 2024.
  • Business Quant data shows Shares Outstanding (Weighted Average) for AEMD at $174529.0 in Q4 2024, $174220.0 in Q3 2024, and $932248.0 in Q2 2024.